Last reviewed · How we verify

NCT06131203: BVS

Burn Validation Study

Completed Last updated 25 April 2025
What this trial tests

trial testing DeepView SnapShot Portable (DV-SSP) in Burns in 274 participants. Completed in 1 April 2025.

Timeline
19 December 2023
Primary endpoint
17 March 2025
1 April 2025

Quick facts

Lead sponsorSpectralMD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment274
Start date19 December 2023
Primary completion17 March 2025
Estimated completion1 April 2025
Sites21 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

SpectralMD

Who can join

Eligibility, any sex, with Burns or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of DeepView SnapShot Portable (DV-SSP)

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other SpectralMD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06131203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing